Is Moderna Winning the COVID-19 Vaccine Race? ETFs to Gain
Moderna, Inc. MRNA raised hopes of a coronavirus vaccine amid these desperate times after it informed about positive interim data from a phase I study evaluating its mRNA-based coronavirus vaccine candidate, mRNA-1273, on May 18. The results reflected ...
from Google Alert - Business https://ift.tt/2zQGZf3
Moderna, Inc. MRNA raised hopes of a coronavirus vaccine amid these desperate times after it informed about positive interim data from a phase I study evaluating its mRNA-based coronavirus vaccine candidate, mRNA-1273, on May 18. The results reflected ... https://ift.tt/eA8V8J
from Google Alert - Business https://ift.tt/2zQGZf3
Moderna, Inc. MRNA raised hopes of a coronavirus vaccine amid these desperate times after it informed about positive interim data from a phase I study evaluating its mRNA-based coronavirus vaccine candidate, mRNA-1273, on May 18. The results reflected ... https://ift.tt/eA8V8J
Comments
Post a Comment